Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes

Cancer Research

Volumn 61, Issue 13, 2001, Pages 5153-5160

  Pinilla, Clemencia ^a   Rubio Godoy, Verena ^b   Dutoit, Valerie ^b   Guillaume, Philippe ^b   Simon, Richard ^c   Zhao, Yindong ^c   Houghten, Richard ^a   Cerottini, Jean Charles ^b   Romero, Pedro ^b   Valmori, Danila ^b  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; EPITOPE; LIGAND; MELAN A; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY; SYNTHETIC PEPTIDE; TUMOR ANTIGEN;

AMINO ACID ANALYSIS; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; BIOMETRY; COMBINATORIAL CHEMISTRY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; PRIORITY JOURNAL; SCREENING; TUMOR IMMUNOLOGY; VACCINE PRODUCTION;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CELL LINE; CLONE CELLS; DATABASES, FACTUAL; EPITOPES, T-LYMPHOCYTE; HUMANS; NEOPLASM PROTEINS; OLIGOPEPTIDES; PEPTIDE LIBRARY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035394234     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Human tumor antigens recognized by T lymphocytes
2. A new era for cancer immunotherapy based on the genes that encode cancer antigens
3. Cytolytic T lymphocyte responses of cancer patients to tumor-associated antigens
4. The role of CD4+ T cell responses in antitumor immunity
5. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
6. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
7. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
8. Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen
9. Structure, chromosomal localization, and expression of 12 genes of the MAGE family
10. Serological identification of human tumor antigens
11. Direct identification of tumor-associated peptide antigens
12. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
13. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
14. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
15. The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands
16. Cyclic peptide template combinatorial libraries: Synthesis and identification of chymotrypsin inhibitors
17. Mixture-based synthetic combinatorial libraries
18. Exploring immunological specificity using synthetic peptide combinatorial libraries
19. 12) sequences
20. Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide
21. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
22. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma
23. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
24. An antigen-targeted approach to adoptive transfer therapy of cancer
25. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease
26. Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: Implications for peptide vaccines
27. Probing degeneracy in T-cell recognition using peptide combinatorial libraries
28. Development and selection of T cells: Facts and puzzles
29. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules
30. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)